Published online before print January 8, 2008
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(IFN-
)Laboratory of Cellular Therapy, Department of Hematology and Oncology, Childrens University Hospital, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany
1 Correspondence: Childrens University Hospital, Friedrich-Alexander University Erlangen-Nuremberg, Loschgestr. 15, D-91054, Erlangen, Germany. E-mail: wolfgang.holter{at}uk-erlangen.de
Current evidence suggests that maturing dendritic cells (DCs) acquire a migratory phenotype to induce T cell responses in lymph nodes or a proinflammatory phenotype to condition the microenvironment at peripheral sites. We show that the interplay of PGE2 and IFN-
generates a more complex pattern of mixed DC phenotypes in response to TLR stimulation. DCs activated by the TLR ligand R-848 in the presence of IFN-
and PGE2 produced high levels of IL-12p70 and IL-23, started migration toward CCL19 within only 10 h, and still continued to secrete IL-12p70 without further restimulation following the migration step. The accelerated onset of migration was a result of PGE2 and was associated with reduced plastic adherence and lower amounts of activated CD29. In contrast, IFN-
by itself enhanced cell adhesion and strongly hindered CCR7-mediated migration in the absence of PGE2. This suggests a new role for IFN-
in the direct regulation of DC migration through enhanced cell adhesion, perhaps to support the development of T cell effector functions at peripheral sites. Together, our data are relevant to the development of DC vaccines, as they demonstrate the existence of dual-functional DCs, which as a result of the simultaneous effects of PGE2 and IFN-
, can migrate rapidly toward lymph node chemokines and carry with them a wave of primary cytokines.
Key Words: R-848 migration CCR7
This article has been cited by other articles:
![]() |
Y. Alvarez, C. Municio, S. Alonso, J. A. S. Roman, M. S. Crespo, and N. Fernandez Cyclooxygenase-2 Induced by Zymosan in Human Monocyte-Derived Dendritic Cells Shows High Stability, and Its Expression Is Enhanced by Atorvastatin J. Pharmacol. Exp. Ther., June 1, 2009; 329(3): 987 - 994. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Boniface, K. S. Bak-Jensen, Y. Li, W. M. Blumenschein, M. J. McGeachy, T. K. McClanahan, B. S. McKenzie, R. A. Kastelein, D. J. Cua, and R. de Waal Malefyt Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling J. Exp. Med., March 16, 2009; 206(3): 535 - 548. [Abstract] [Full Text] [PDF] |
||||